1699-59-8 Usage
Description
3,4-Dibenzyloxybenzyl chloride is an organic compound that appears as an almost white to light beige powder. It is characterized by its chemical structure, which includes a central benzene ring with two benzyloxy groups attached at the 3 and 4 positions, and a chlorine atom attached to the benzyl group.
Uses
Used in Pharmaceutical Industry:
3,4-Dibenzyloxybenzyl chloride is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a versatile building block in the creation of new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
In the field of organic chemistry, 3,4-Dibenzyloxybenzyl chloride is used as a precursor for the preparation of benzylnitrile, which is an essential compound in the synthesis of amidines. Amidines are important in the development of various chemical products, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Research and Development:
Due to its unique chemical properties and structure, 3,4-Dibenzyloxybenzyl chloride is also utilized in research and development for the exploration of new chemical reactions and the creation of novel compounds with potential applications in various industries, such as materials science, pharmaceuticals, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1699-59-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,9 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1699-59:
(6*1)+(5*6)+(4*9)+(3*9)+(2*5)+(1*9)=118
118 % 10 = 8
So 1699-59-8 is a valid CAS Registry Number.
InChI:InChI=1/C21H19ClO2/c22-14-19-11-12-20(23-15-17-7-3-1-4-8-17)21(13-19)24-16-18-9-5-2-6-10-18/h1-13H,14-16H2
1699-59-8Relevant articles and documents
Designing new analogs for streamlining the structure of cytotoxic lamellarin natural products
Tangdenpaisal, Kassrin,Worayuthakarn, Rattana,Karnkla, Supatra,Ploypradith, Poonsakdi,Intachote, Pakamas,Sengsai, Suchada,Saimanee, Busakorn,Ruchirawat, Somsak,Chittchang, Montakarn
, p. 925 - 937 (2015/03/31)
Despite the therapeutic potential of marine-derived lamellarin natural products, their preclinical development has been hampered by their lipophilic nature, causing very poor aqueous solubility. In order to develop more drug-like analogs, their structure was streamlined in this study from both the cytotoxic activity and lipophilicity standpoints. First, a modified total synthetic route was successfully devised to construct a library of 59 systematically designed lamellarin analogs, which were then subjected to cytotoxicity and log P determinations. Along with the 25 first-generation lamellarins previously synthesized in our laboratory, the structure-activity and structure-lipophilicity relationships were extensively evaluated. Our results clearly indicated the additional structural requirements around the lamellarin skeleton which, when combined with those reported previously, can provide invaluable guidance for further modifications to increase the aqueous solubility of these compounds.
CAFFEINATED COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES
-
, (2013/05/21)
Compounds and their pharmaceutically acceptable salts for treatment of Beta-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease